Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Brexpiprazole Tablets bulk supplier for pharma manufacturers

Brexpiprazole Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg

Reference Brands: Rexulti®(US & EU)

Category: Psychiatry / Mental Health

Brexpiprazole is an atypical antipsychotic that acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and an antagonist at 5-HT2A receptors. This balanced activity helps modulate dopamine and serotonin pathways in the brain. It is used for the treatment of schizophrenia and as an adjunctive therapy for major depressive disorder (MDD) in adults, offering improved mood stabilization and reduced psychotic symptoms with a lower risk of extrapyramidal side effects.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Brexpiprazole tablets are FDA-approved in the United States for the treatment of schizophrenia and as an adjunctive therapy for major depressive disorder (MDD) in adults. In the European Union, Brexpiprazole is approved under brand names like Rxulti, primarily for schizophrenia, following centralized EMA procedures. Regulatory compliance includes GMP standards, comprehensive clinical data, and documentation on metabolic side effects, akathisia, and suicidality risks. U.S. submissions must meet FDA requirements including boxed warnings for elderly dementia-related psychosis. EMA approval mandates a full Risk Management Plan (RMP) and pharmacovigilance commitments. For dossier-ready Brexpiprazole tablets and sourcing options, visit Pharmatradz.com — your trusted B2B pharma platform.

Brexpiprazole Tablets — third party manufacturing & bulk supply

Brexpiprazole Tablets is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Brexpiprazole Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Brexpiprazole Tablets →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Brexpiprazole is used to treat psychiatric conditions such as schizophrenia and as an adjunct therapy for major depressive disorder. It helps improve mood, reduce psychotic symptoms, and enhance overall functioning in patients with mental health disorders.

Brexpiprazole is a synthetic pharmaceutical compound that acts as a serotonin–dopamine activity modulator. It is manufactured under controlled pharmaceutical processes to ensure purity, stability, and consistent therapeutic effects.

Brexpiprazole is marketed under the brand name Rexulti in the United States and other regions.

Brexpiprazole (Rexulti) is manufactured and marketed by Otsuka Pharmaceutical Co., Ltd. in partnership with other authorized distributors depending on the region.

The generic name is Brexpiprazole.

The most recognized brand name is Rexulti.

Brexpiprazole is manufactured in regulated pharmaceutical facilities that comply with international quality standards, including sites in the United States, Japan, and other regions where the product is approved for use.

Related Products

Esketamine

Strength:
28 mg

Form: Nasal spray

Reference Brands: Spravato (USA/EU)

View Details
Agomelatine

Strength:
25 mg, 50 mg

Form: Tablets

Reference Brands: Valdoxan (EU/UK), Thymanax (India/ Middle East)

View Details
Bupropion Hydrobromide

Strength:
75 mg, 100 mg, 150mg, 300 mg

Form: Tablets

Reference Brands: Wellbutrin (USA), Zyban (USA)

View Details
Vortioxetine Film-Coated Tablets

Strength:
5 mg, 10 mg, 15 mg(EU only), 20 mg

Form: Film-Coated Tablets

Reference Brands: Trintellix®(US); Brintellix®(EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.